XML 103 R4.htm IDEA: XBRL DOCUMENT v3.20.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Income Statement [Abstract]      
Revenue $ 12,985 $ 129  
Expenses:      
Cost of sales (3,749) (43)  
Research and development (142,221) (120,278) $ (39,342)
Selling, general and administrative (70,211) (21,576) (12,049)
Loss from operations (203,196) (141,768) (51,391)
Interest income 8,232 3,261 527
Interest expenses (293) (40)  
Changes in fair value of warrants     200
Other income, net 938 59 530
Loss before income tax and share of loss from equity method investment (194,319) (138,488) (50,134)
Income tax expense 0    
Share of loss from equity method investment (752) (587) (250)
Net loss (195,071) (139,075) (50,384)
Net loss attributable to ordinary shareholders $ (195,071) $ (139,075) $ (50,384)
Loss per share - basic and diluted $ (3.03) $ (2.64) $ (2.32)
Weighted-average shares used in calculating net loss per ordinary share - basic and diluted 64,369,490 52,609,810 21,752,757